Zum Inhalt springen

Nur-Lesen-Fassung: Das Forschungsinformationssystem (FIS) ist aus Sicherheitsgründen vorübergehend durch diese Nur-Lesen-Fassung ersetzt. Alle öffentlichen Inhalte und Volltexte sind weiterhin abrufbar; Anmeldung, Bearbeitung, Einreichung und Statistiken stehen nicht zur Verfügung. Bei Fragen: fis@uni-bamberg.de

Start › Publikationen › Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder-Preliminary Results of the PROVIT Study

Publikation

Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder-Preliminary Results of the PROVIT Study

Reiter, Alexandra; Bengesser, Susanne A.; Hauschild, Anne-Christin; u. a. (2021): Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder-Preliminary Results of the PROVIT Study, in: Bamberg: Otto-Friedrich-Universität, S. 1–17.

Details

Fakultät/Lehrstuhl
Autorin(nen)/Autor(en)
Reiter, Alexandra; Bengesser, Susanne A.; Hauschild, Anne-Christin; Birkl-Töglhofer, Anna-Maria; Fellendorf, Frederike T.; Platzer, Martina; ORCID iDFärber, Tanja; Seidl, Matthias; Mendel, Lilli-Marie; Unterweger, Renate; Lenger, Melanie; Mörkl, Sabrina; Dalkner, Nina; Birner, Armin; Queissner, Robert; Hamm, Carlo; Maget, Alexander; Pilz, Rene; Kohlhammer-Dohr, Alexandra; Wagner-Skacel, Jolana; Kreuzer, Kathrin; Schöggl, Helmut; Amberger-Otti, Daniela; Lahousen, Theresa; Leitner-Afschar, Birgitta; Haybäck, Johannes; Kapfhammer, Hans-Peter; Reininghaus, Eva
Verlagsangabe
Otto-Friedrich-Universität : Bamberg
Erscheinungsjahr
2021
Quelle/Weitere Ausgabe
Nutrients, 12 (2020), 2575, S. 1-17 - ISSN: 2072-6643
Jahr der Erstpublikation
2020
Sprache(n)
Englisch
Lizenz
URN
Abstract

Major depressive disorder (MDD) is a prevalent disease, in which one third of sufferers do not respond to antidepressants. Probiotics have the potential to be well-tolerated and cost-effcient treatment options. However, the molecular pathways of their effects are not fully elucidated yet. Based on previous literature, we assume that probiotics can positively influence inflammatory mechanisms. We aimed at analyzing the effects of probiotics on gene expression of inflammation genes as part of the randomized, placebo-controlled, multispecies probiotics PROVIT study in Graz, Austria. Fasting blood of 61 inpatients with MDD was collected before and after four weeks of probiotic intake or placebo. We analyzed the effects on gene expression of tumor necrosis factor (TNF), nuclear factor kappa B subunit 1 (NFKB1) and interleukin-6 (IL-6). In IL-6 we found no significant main effects for group (F(1,44) = 1.33, p = ns) nor time (F(1,44) = 0.00, p = ns), but interaction was significant (F(1,44) = 5.67, p < 0.05). The intervention group showed decreasing IL-6 gene expression levels while the placebo group showed increasing gene expression levels of IL-6. Probiotics could be a useful additional treatment in MDD, due to their anti-inflammatory effects. Results of the current study are promising, but further studies are required to investigate the beneficial effects of probiotic interventions in depressed individuals.

Freie Schlagwort(e)
depression
gut-brain-axis
probiotics
gene expression
interleukin-6
Peer Reviewed
ja
Internationale Verbreitung
ja
Open-Access-Zeitschrift
ja
Dokumenttyp
Artikel in einer Zeitschrift / Postprint
URI
Datum der Freischaltung
28.04.2021

Permalink: https://fis.uni-bamberg.de/handle/uniba/49765 · Daten als JSON · Zitieren: BibTeX · RIS

Datenstand: 16.11.2026

Eingeschränkter Lesezugriff: Anmeldung, Bearbeitung und Einreichung sind vorübergehend deaktiviert.